Symbol:
UPP1
Name:
uridine phosphorylase 1
RGD ID:
1313669
HGNC Page
HGNC:12576
Description:
Enables identical protein binding activity and uridine phosphorylase activity. Involved in uridine catabolic process. Located in nucleoplasm.
Type:
protein-coding
RefSeq Status:
REVIEWED
Previously known as:
UDRPASE; UP; UPASE; UPase 1; UPP; urdPase 1
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Upp1 (uridine phosphorylase 1)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Upp1 (uridine phosphorylase 1)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Upp1 (uridine phosphorylase 1)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
UPP1 (uridine phosphorylase 1)
NCBI
Ortholog
Canis lupus familiaris (dog):
UPP1 (uridine phosphorylase 1)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Upp1 (uridine phosphorylase 1)
NCBI
Ortholog
Sus scrofa (pig):
UPP1 (uridine phosphorylase 1)
HGNC
EggNOG, Ensembl, NCBI, OMA, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):
UPP1 (uridine phosphorylase 1)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Upp1 (uridine phosphorylase 1)
NCBI
Ortholog
Other homologs 2
Rattus norvegicus (Norway rat):
Sfmbt1 (Scm-like with four mbt domains 1)
HGNC
OMA
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Upp1 (uridine phosphorylase 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Upp1 (uridine phosphorylase 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
upp1 (uridine phosphorylase 1)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB|ZFIN)
Caenorhabditis elegans (roundworm):
upp-1
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG3788
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG6330
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
upp1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus laevis (African clawed frog):
upp1.L
Alliance
DIOPT (Xenbase)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 7 48,088,704 - 48,108,736 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 7 48,088,628 - 48,108,736 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 7 48,128,301 - 48,148,333 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 7 48,094,880 - 48,114,855 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 7 48,227,538 - 48,247,515 (+) NCBI Celera Cytogenetic Map 7 p12.3 NCBI HuRef 7 48,013,948 - 48,033,924 (+) NCBI HuRef CHM1_1 7 48,132,055 - 48,152,030 (+) NCBI CHM1_1 T2T-CHM13v2.0 7 48,250,938 - 48,270,970 (+) NCBI T2T-CHM13v2.0 CRA_TCAGchr7v2 7 48,168,224 - 48,188,201 (+) NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
UPP1 Human (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of UPP1 mRNA CTD PMID:23825647 UPP1 Human 17alpha-ethynylestradiol increases expression ISO RGD:1313670 6480464 Ethinyl Estradiol results in increased expression of UPP1 mRNA CTD PMID:17942748 UPP1 Human 17alpha-ethynylestradiol increases expression ISO RGD:1305566 6480464 Ethinyl Estradiol results in increased expression of UPP1 mRNA CTD PMID:17557909 UPP1 Human 17alpha-ethynylestradiol multiple interactions ISO RGD:1313670 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA CTD PMID:17942748 UPP1 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of UPP1 mRNA CTD PMID:20106945|PMID:31614463 UPP1 Human 17beta-estradiol decreases expression ISO RGD:1313670 6480464 Estradiol results in decreased expression of UPP1 mRNA CTD PMID:39298647 UPP1 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of UPP1 mRNA CTD PMID:20660070 UPP1 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of UPP1 mRNA CTD PMID:31173147 UPP1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA CTD PMID:16704738 UPP1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1305566 6480464 Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA CTD PMID:33387578 UPP1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1305566 6480464 Tetrachlorodibenzodioxin affects the expression of UPP1 mRNA CTD PMID:34747641 UPP1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313670 6480464 Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA CTD PMID:26290441 UPP1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313670 6480464 Tetrachlorodibenzodioxin affects the expression of UPP1 mRNA CTD PMID:21570461|PMID:26377647 UPP1 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UPP1 mRNA CTD PMID:20106945|PMID:21632981 UPP1 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313670 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA CTD PMID:17942748 UPP1 Human 2,4-diaminotoluene increases expression ISO RGD:1313670 6480464 2,4-diaminotoluene results in increased expression of UPP1 mRNA CTD PMID:20713471 UPP1 Human 2,4-dinitrotoluene affects expression ISO RGD:1305566 6480464 2,4-dinitrotoluene affects the expression of UPP1 mRNA CTD PMID:21346803 UPP1 Human 2,6-dimethoxyphenol multiple interactions EXP 6480464 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the more ... CTD PMID:38598786 UPP1 Human 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of UPP1 mRNA CTD PMID:30851411 UPP1 Human 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1313670 6480464 tetrabromobisphenol A results in increased expression of UPP1 mRNA CTD PMID:25172293 UPP1 Human 3-chloropropane-1,2-diol increases expression ISO RGD:1305566 6480464 alpha-Chlorohydrin results in increased expression of UPP1 protein CTD PMID:34915118 UPP1 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 UPP1 Human 3-methylcholanthrene increases expression ISO RGD:1313670 6480464 Methylcholanthrene results in increased expression of UPP1 mRNA CTD PMID:20713471 UPP1 Human 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1313670 6480464 4,4'-diaminodiphenylmethane results in decreased expression of UPP1 mRNA CTD PMID:18648102 UPP1 Human 4,4'-sulfonyldiphenol increases expression ISO RGD:1313670 6480464 bisphenol S results in increased expression of UPP1 mRNA CTD PMID:30951980 UPP1 Human 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1305566 6480464 Oxazolone results in increased expression of UPP1 mRNA CTD PMID:21893156 UPP1 Human 4-hydroxyphenyl retinamide increases expression ISO RGD:1313670 6480464 Fenretinide results in increased expression of UPP1 mRNA CTD PMID:28973697 UPP1 Human 5-benzyl-1-(2-hydroxyethoxymethyl)uracil multiple interactions ISO RGD:1313670 6480464 5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results more ... CTD PMID:16397116 UPP1 Human 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of UPP1 mRNA; Fluorouracil results in increased expression of UPP1 more ... CTD PMID:15109396|PMID:15331170|PMID:24737281 UPP1 Human 5-fluorouracil affects response to substance ISO RGD:1313670 6480464 UPP1 protein affects the susceptibility to Fluorouracil CTD PMID:15772079 UPP1 Human 5-fluorouracil multiple interactions ISO RGD:1313670 6480464 [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil CTD PMID:15772079 UPP1 Human 5-fluorouracil affects response to substance EXP 6480464 UPP1 affects the susceptibility to Fluorouracil CTD PMID:15067352 UPP1 Human 6-propyl-2-thiouracil decreases expression ISO RGD:1305566 6480464 Propylthiouracil results in decreased expression of UPP1 mRNA CTD PMID:24780913 UPP1 Human 6-propyl-2-thiouracil increases expression ISO RGD:1305566 6480464 Propylthiouracil results in increased expression of UPP1 mRNA CTD PMID:30047161 UPP1 Human acetamide increases expression ISO RGD:1305566 6480464 acetamide results in increased expression of UPP1 mRNA CTD PMID:31881176 UPP1 Human aconitine decreases expression ISO RGD:1305566 6480464 Aconitine results in decreased expression of UPP1 protein CTD PMID:33236894 UPP1 Human adenosine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of Adenosine CTD PMID:15772079 UPP1 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of UPP1 protein CTD PMID:20106945 UPP1 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of UPP1 mRNA CTD PMID:27153756 UPP1 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of UPP1 mRNA CTD PMID:23724009|PMID:23830798|PMID:33167477 UPP1 Human alpha-Zearalanol multiple interactions ISO RGD:1305566 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of UPP1 mRNA CTD PMID:35163327 UPP1 Human amitrole increases expression ISO RGD:1305566 6480464 Amitrole results in increased expression of UPP1 mRNA CTD PMID:30047161 UPP1 Human amphetamine increases expression ISO RGD:1305566 6480464 Amphetamine results in increased expression of UPP1 mRNA CTD PMID:30779732 UPP1 Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of UPP1 mRNA CTD PMID:24449571 UPP1 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of UPP1 mRNA CTD PMID:33212167 UPP1 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of UPP1 gene CTD PMID:25304211 UPP1 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of UPP1 gene CTD PMID:25304211 UPP1 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of UPP1 mRNA CTD PMID:27829220 UPP1 Human azathioprine increases expression EXP 6480464 Azathioprine results in increased expression of UPP1 mRNA CTD PMID:22623647 UPP1 Human benzo[a]pyrene increases expression ISO RGD:1313670 6480464 Benzo(a)pyrene results in increased expression of UPP1 mRNA CTD PMID:22228805|PMID:23735875|PMID:32417428 UPP1 Human benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of UPP1 5' UTR CTD PMID:27901495 UPP1 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of UPP1 mRNA CTD PMID:21632981|PMID:26238291 UPP1 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of UPP1 mRNA CTD PMID:38218311 UPP1 Human bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of UPP1 mRNA CTD PMID:15638997 UPP1 Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of UPP1 mRNA CTD PMID:31163220 UPP1 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UPP1 mRNA CTD PMID:20678512 UPP1 Human bisphenol A decreases expression ISO RGD:1305566 6480464 bisphenol A results in decreased expression of UPP1 mRNA CTD PMID:30816183|PMID:32528016|PMID:34947998 UPP1 Human bisphenol A multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 UPP1 Human bisphenol A increases expression ISO RGD:1305566 6480464 bisphenol A results in increased expression of UPP1 mRNA CTD PMID:25181051|PMID:32145629 UPP1 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UPP1 mRNA CTD PMID:20170705|PMID:30903817 UPP1 Human bisphenol F increases expression ISO RGD:1313670 6480464 bisphenol F results in increased expression of UPP1 mRNA CTD PMID:30951980 UPP1 Human bleomycin A5 decreases expression EXP 6480464 bleomycetin results in decreased expression of UPP1 mRNA CTD PMID:21040473 UPP1 Human bortezomib multiple interactions ISO RGD:1313670 6480464 Bortezomib inhibits the reaction [TNF protein results in increased activity of UPP1 protein]; Bortezomib inhibits more ... CTD PMID:16397116 UPP1 Human bortezomib decreases activity ISO RGD:1313670 6480464 Bortezomib results in decreased activity of UPP1 protein CTD PMID:16397116 UPP1 Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of UPP1 mRNA CTD PMID:26079696 UPP1 Human cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of UPP1 mRNA CTD PMID:21172416 UPP1 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of UPP1 mRNA CTD PMID:38568856 UPP1 Human calciol decreases expression ISO RGD:1313670 6480464 Cholecalciferol results in decreased expression of UPP1 mRNA CTD PMID:16508948 UPP1 Human calyculin A increases expression ISO RGD:1313670 6480464 calyculin A results in increased expression of UPP1 mRNA CTD PMID:25270620 UPP1 Human cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of UPP1 mRNA CTD PMID:33244087 UPP1 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of UPP1 mRNA CTD PMID:25979313 UPP1 Human carbon nanotube increases expression ISO RGD:1313670 6480464 Nanotubes, Carbon analog results in increased expression of UPP1 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681 UPP1 Human carbon nanotube decreases expression ISO RGD:1313670 6480464 Nanotubes, Carbon results in decreased expression of UPP1 mRNA CTD PMID:25620056 UPP1 Human cefaloridine increases expression ISO RGD:1305566 6480464 Cephaloridine results in increased expression of UPP1 mRNA CTD PMID:18500788 UPP1 Human chlordecone increases expression ISO RGD:1313670 6480464 Chlordecone results in increased expression of UPP1 mRNA CTD PMID:33711761 UPP1 Human chloropicrin affects expression EXP 6480464 chloropicrin affects the expression of UPP1 mRNA CTD PMID:26352163 UPP1 Human chloroprene decreases expression ISO RGD:1313670 6480464 Chloroprene results in decreased expression of UPP1 mRNA CTD PMID:23125180 UPP1 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of UPP1 mRNA CTD PMID:27392435 UPP1 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of UPP1 mRNA CTD PMID:27392435 UPP1 Human cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of UPP1 mRNA CTD PMID:19320972|PMID:19376846|PMID:22941251 UPP1 Human copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA CTD PMID:20971185 UPP1 Human copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA CTD PMID:20971185 UPP1 Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of UPP1 mRNA CTD PMID:38568856 UPP1 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of UPP1 mRNA CTD PMID:19549813 UPP1 Human crocidolite asbestos affects expression EXP 6480464 Asbestos, Crocidolite affects the expression of UPP1 mRNA CTD PMID:25757056 UPP1 Human crotonaldehyde increases expression EXP 6480464 2-butenal results in increased expression of UPP1 mRNA CTD PMID:20471460 UPP1 Human Cuprizon increases expression ISO RGD:1305566 6480464 Cuprizone results in increased expression of UPP1 mRNA CTD PMID:26577399 UPP1 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of UPP1 mRNA CTD PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131 UPP1 Human cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of UPP1 mRNA CTD PMID:24921660 UPP1 Human cytidine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of Cytidine CTD PMID:15772079 UPP1 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 UPP1 Human dextran sulfate decreases expression ISO RGD:1313670 6480464 Dextran Sulfate results in decreased expression of UPP1 protein CTD PMID:35362542 UPP1 Human dextran sulfate multiple interactions ISO RGD:1313670 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UPP1 protein] CTD PMID:35362542 UPP1 Human diallyl disulfide multiple interactions EXP 6480464 diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of UPP1 mRNA] CTD PMID:36758788 UPP1 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of UPP1 mRNA CTD PMID:27829220 UPP1 Human dibutyl phthalate decreases expression ISO RGD:1313670 6480464 Dibutyl Phthalate results in decreased expression of UPP1 mRNA CTD PMID:21266533 UPP1 Human dioxygen multiple interactions EXP 6480464 Oxygen inhibits the reaction [darinaparsin results in increased expression of UPP1 mRNA] CTD PMID:22535156 UPP1 Human diquat increases expression EXP 6480464 Diquat results in increased expression of UPP1 mRNA CTD PMID:21172416 UPP1 Human disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of UPP1 mRNA CTD PMID:24383545 UPP1 Human diuron decreases expression EXP 6480464 Diuron results in decreased expression of UPP1 mRNA CTD PMID:35967413 UPP1 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 UPP1 Human doxifluridine multiple interactions ISO RGD:1313670 6480464 5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results more ... CTD PMID:16397116 UPP1 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of UPP1 mRNA CTD PMID:18510171 UPP1 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of UPP1 mRNA CTD PMID:29803840 UPP1 Human endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of UPP1 mRNA CTD PMID:26615145 UPP1 Human ethanol increases expression EXP 6480464 Ethanol results in increased expression of UPP1 mRNA CTD PMID:28986285 UPP1 Human Evodiamine multiple interactions ISO RGD:1313670 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UPP1 protein] CTD PMID:35362542 UPP1 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of UPP1 mRNA CTD PMID:27664576 UPP1 Human furfural multiple interactions EXP 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of UPP1 protein; [Sodium Chloride co-treated more ... CTD PMID:38598786 UPP1 Human guanosine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of Guanosine CTD PMID:15772079 UPP1 Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of UPP1 mRNA CTD PMID:20044591 UPP1 Human hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of UPP1 mRNA CTD PMID:31256213 UPP1 Human indometacin increases expression EXP 6480464 Indomethacin results in increased expression of UPP1 mRNA CTD PMID:16984733 UPP1 Human indometacin increases expression ISO RGD:1305566 6480464 Indomethacin results in increased expression of UPP1 mRNA CTD PMID:36868495 UPP1 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 UPP1 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of UPP1 protein CTD PMID:32959892 UPP1 Human Licochalcone B increases expression EXP 6480464 licochalcone B results in increased expression of UPP1 mRNA CTD PMID:33647349 UPP1 Human manganese(II) chloride increases expression ISO RGD:1305566 6480464 manganese chloride results in increased expression of UPP1 mRNA CTD PMID:28801915 UPP1 Human menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of UPP1 mRNA CTD PMID:20044591 UPP1 Human menadione decreases expression ISO RGD:1313670 6480464 Vitamin K 3 results in decreased expression of UPP1 mRNA CTD PMID:25270620 UPP1 Human mercury dichloride increases expression ISO RGD:1305566 6480464 Mercuric Chloride results in increased expression of UPP1 mRNA CTD PMID:16507785 UPP1 Human methamphetamine increases expression ISO RGD:1305566 6480464 Methamphetamine results in increased expression of UPP1 mRNA CTD PMID:19564919 UPP1 Human methamphetamine multiple interactions ISO RGD:1305566 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of UPP1 mRNA CTD PMID:19564919 UPP1 Human methimazole increases expression ISO RGD:1305566 6480464 Methimazole results in increased expression of UPP1 mRNA CTD PMID:30047161 UPP1 Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of UPP1 mRNA CTD PMID:17379860 UPP1 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of UPP1 mRNA CTD PMID:28001369 UPP1 Human methylmercury chloride increases expression ISO RGD:1305566 6480464 methylmercuric chloride results in increased expression of UPP1 mRNA CTD PMID:31378766 UPP1 Human methylparaben increases expression EXP 6480464 methylparaben results in increased expression of UPP1 mRNA CTD PMID:31745603 UPP1 Human Monobutylphthalate affects expression ISO RGD:1313670 6480464 monobutyl phthalate affects the expression of UPP1 mRNA CTD PMID:19162170 UPP1 Human N-methyl-4-phenylpyridinium increases expression ISO RGD:1305566 6480464 1-Methyl-4-phenylpyridinium results in increased expression of UPP1 mRNA CTD PMID:28801915 UPP1 Human N-methyl-N-nitrosourea increases expression ISO RGD:1305566 6480464 Methylnitrosourea results in increased expression of UPP1 mRNA CTD PMID:17412507 UPP1 Human N-methyl-N-nitrosourea decreases expression ISO RGD:1313670 6480464 Methylnitrosourea results in decreased expression of UPP1 mRNA CTD PMID:25270620 UPP1 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of UPP1 mRNA CTD PMID:24768652|PMID:25583101 UPP1 Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of UPP1 mRNA CTD PMID:18651567 UPP1 Human nicotine increases expression EXP 6480464 Nicotine results in increased expression of UPP1 mRNA CTD PMID:23825647 UPP1 Human obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of UPP1 mRNA CTD PMID:27939613 UPP1 Human okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of UPP1 mRNA CTD PMID:38832940 UPP1 Human oxaliplatin multiple interactions ISO RGD:1305566 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of UPP1 mRNA CTD PMID:25729387 UPP1 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of UPP1 mRNA CTD PMID:29067470 UPP1 Human paracetamol increases expression ISO RGD:1305566 6480464 Acetaminophen results in increased expression of UPP1 mRNA CTD PMID:33387578 UPP1 Human paraquat increases expression ISO RGD:1305566 6480464 Paraquat results in increased expression of UPP1 mRNA CTD PMID:32680482 UPP1 Human pentobarbital affects response to substance ISO RGD:1313670 6480464 UPP1 protein affects the susceptibility to Pentobarbital CTD PMID:15772079 UPP1 Human pentobarbital multiple interactions ISO RGD:1313670 6480464 [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital CTD PMID:15772079 UPP1 Human perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of UPP1 mRNA CTD PMID:32588087 UPP1 Human perfluorooctanoic acid multiple interactions ISO RGD:1305566 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of UPP1 mRNA CTD PMID:35163327 UPP1 Human phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of UPP1 mRNA CTD PMID:19084549 UPP1 Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of UPP1 mRNA CTD PMID:19159669 UPP1 Human pirinixic acid decreases expression ISO RGD:1313670 6480464 pirinixic acid results in decreased expression of UPP1 mRNA CTD PMID:17426115 UPP1 Human pirinixic acid increases expression ISO RGD:1313670 6480464 pirinixic acid results in increased expression of UPP1 mRNA CTD PMID:18301758|PMID:20813756 UPP1 Human progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of UPP1 mRNA CTD PMID:20660070 UPP1 Human pyrimidine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of pyrimidine CTD PMID:15772079 UPP1 Human rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of UPP1 mRNA CTD PMID:30851411 UPP1 Human resveratrol increases expression ISO RGD:1305566 6480464 resveratrol results in increased expression of UPP1 mRNA CTD PMID:25905778 UPP1 Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of UPP1 mRNA CTD PMID:23557933 UPP1 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 UPP1 Human SCH 23390 multiple interactions ISO RGD:1305566 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of UPP1 mRNA CTD PMID:19564919 UPP1 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of UPP1 mRNA CTD PMID:25895662 UPP1 Human silicon dioxide increases expression ISO RGD:1313670 6480464 Silicon Dioxide results in increased expression of UPP1 mRNA CTD PMID:23221170 UPP1 Human sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of UPP1 mRNA CTD PMID:12727804 UPP1 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of UPP1 mRNA CTD PMID:38568856 UPP1 Human sodium chloride multiple interactions EXP 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of UPP1 protein; [Sodium Chloride co-treated more ... CTD PMID:38598786 UPP1 Human succimer multiple interactions ISO RGD:1313670 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of UPP1 mRNA CTD PMID:21641980 UPP1 Human sulfadimethoxine increases expression ISO RGD:1305566 6480464 Sulfadimethoxine results in increased expression of UPP1 mRNA CTD PMID:30047161 UPP1 Human sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of UPP1 mRNA CTD PMID:31838189 UPP1 Human sulindac sulfide increases expression EXP 6480464 sulindac sulfide results in increased expression of UPP1 mRNA CTD PMID:16184548 UPP1 Human tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of UPP1 mRNA CTD PMID:15336504 UPP1 Human thalidomide decreases expression ISO RGD:1313670 6480464 Thalidomide results in decreased expression of UPP1 mRNA CTD PMID:26217789 UPP1 Human thimerosal increases expression EXP 6480464 Thimerosal results in increased expression of UPP1 mRNA CTD PMID:16870260 UPP1 Human thioacetamide increases expression ISO RGD:1305566 6480464 Thioacetamide results in increased expression of UPP1 mRNA CTD PMID:34492290 UPP1 Human thiram increases expression EXP 6480464 Thiram results in increased expression of UPP1 mRNA CTD PMID:38568856 UPP1 Human topotecan multiple interactions ISO RGD:1305566 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of UPP1 mRNA CTD PMID:25729387 UPP1 Human topotecan increases expression ISO RGD:1305566 6480464 Topotecan results in increased expression of UPP1 mRNA CTD PMID:25729387 UPP1 Human tributylstannane increases expression ISO RGD:1313670 6480464 tributyltin results in increased expression of UPP1 mRNA CTD PMID:31939706 UPP1 Human trichloroethene increases expression ISO RGD:1305566 6480464 Trichloroethylene results in increased expression of UPP1 mRNA CTD PMID:33387578 UPP1 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of UPP1 mRNA CTD PMID:26272509 UPP1 Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 UPP1 Human trimellitic anhydride increases expression ISO RGD:1305566 6480464 trimellitic anhydride results in increased expression of UPP1 mRNA CTD PMID:21893156 UPP1 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of UPP1 mRNA CTD PMID:37042841 UPP1 Human Triptolide increases expression ISO RGD:1305566 6480464 triptolide results in increased expression of UPP1 protein CTD PMID:32519852 UPP1 Human tris(2-butoxyethyl) phosphate increases expression EXP 6480464 tris(2-butoxyethyl) phosphate results in increased expression of UPP1 mRNA CTD PMID:29024780 UPP1 Human trovafloxacin multiple interactions ISO RGD:1313670 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of UPP1 mRNA CTD PMID:18930950 UPP1 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of UPP1 mRNA CTD PMID:29453283 UPP1 Human urethane increases expression EXP 6480464 Urethane results in increased expression of UPP1 mRNA CTD PMID:28818685 UPP1 Human uridine affects abundance ISO RGD:1313670 6480464 UPP1 protein affects the abundance of Uridine CTD PMID:15772079 UPP1 Human uridine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of Uridine CTD PMID:15772079 UPP1 Human uridine multiple interactions ISO RGD:1313670 6480464 [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil; [UPP1 more ... CTD PMID:15772079 UPP1 Human valproic acid decreases expression ISO RGD:1313670 6480464 Valproic Acid results in decreased expression of UPP1 mRNA CTD PMID:19136453 UPP1 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of UPP1 mRNA CTD PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799 UPP1 Human zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of UPP1 mRNA CTD PMID:24714768
Imported Annotations - KEGG (archival)
(S)-nicotine (EXP) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-diaminotoluene (ISO) 2,4-dinitrotoluene (ISO) 2,6-dimethoxyphenol (EXP) 2-hydroxypropanoic acid (EXP) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-chloropropane-1,2-diol (ISO) 3-isobutyl-1-methyl-7H-xanthine (EXP) 3-methylcholanthrene (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 4-(ethoxymethylene)-2-phenyloxazol-5-one (ISO) 4-hydroxyphenyl retinamide (ISO) 5-benzyl-1-(2-hydroxyethoxymethyl)uracil (ISO) 5-fluorouracil (EXP,ISO) 6-propyl-2-thiouracil (ISO) acetamide (ISO) aconitine (ISO) adenosine (ISO) aflatoxin B1 (EXP) all-trans-retinoic acid (EXP) alpha-Zearalanol (ISO) amitrole (ISO) amphetamine (ISO) antirheumatic drug (EXP) aristolochic acid A (EXP) arsane (EXP) arsenic atom (EXP) arsenous acid (EXP) azathioprine (EXP) benzo[a]pyrene (EXP,ISO) beta-lapachone (EXP) bicalutamide (EXP) bis(2-ethylhexyl) phthalate (EXP) bisphenol A (EXP,ISO) bisphenol F (ISO) bleomycin A5 (EXP) bortezomib (ISO) butanal (EXP) cadmium atom (EXP) cadmium dichloride (EXP) calciol (ISO) calyculin A (ISO) cannabidiol (EXP) carbamazepine (EXP) carbon nanotube (ISO) cefaloridine (ISO) chlordecone (ISO) chloropicrin (EXP) chloroprene (ISO) cisplatin (EXP) cobalt dichloride (EXP) copper atom (EXP) copper(0) (EXP) copper(II) chloride (EXP) copper(II) sulfate (EXP) crocidolite asbestos (EXP) crotonaldehyde (EXP) Cuprizon (ISO) cyclosporin A (EXP) cylindrospermopsin (EXP) cytidine (ISO) dexamethasone (EXP) dextran sulfate (ISO) diallyl disulfide (EXP) diarsenic trioxide (EXP) dibutyl phthalate (ISO) dioxygen (EXP) diquat (EXP) disodium selenite (EXP) diuron (EXP) dorsomorphin (EXP) doxifluridine (ISO) doxorubicin (EXP) endosulfan (EXP) ethanol (EXP) Evodiamine (ISO) formaldehyde (EXP) furfural (EXP) guanosine (ISO) hydrogen peroxide (EXP) hydroquinone (EXP) indometacin (EXP,ISO) ivermectin (EXP) Licochalcone B (EXP) manganese(II) chloride (ISO) menadione (EXP,ISO) mercury dichloride (ISO) methamphetamine (ISO) methimazole (ISO) methotrexate (EXP) methylmercury chloride (EXP,ISO) methylparaben (EXP) Monobutylphthalate (ISO) N-methyl-4-phenylpyridinium (ISO) N-methyl-N-nitrosourea (ISO) nickel atom (EXP) nickel sulfate (EXP) nicotine (EXP) obeticholic acid (EXP) okadaic acid (EXP) oxaliplatin (ISO) paracetamol (EXP,ISO) paraquat (ISO) pentobarbital (ISO) perfluorononanoic acid (EXP) perfluorooctanoic acid (ISO) phenobarbital (EXP) pirinixic acid (ISO) progesterone (EXP) pyrimidine (ISO) rac-lactic acid (EXP) resveratrol (EXP,ISO) SB 431542 (EXP) SCH 23390 (ISO) silicon dioxide (EXP,ISO) sodium arsenate (EXP) sodium arsenite (EXP) sodium chloride (EXP) succimer (ISO) sulfadimethoxine (ISO) sulforaphane (EXP) sulindac sulfide (EXP) tert-butyl hydroperoxide (EXP) thalidomide (ISO) thimerosal (EXP) thioacetamide (ISO) thiram (EXP) topotecan (ISO) tributylstannane (ISO) trichloroethene (ISO) trichostatin A (EXP) trimellitic anhydride (ISO) triphenyl phosphate (EXP) Triptolide (ISO) tris(2-butoxyethyl) phosphate (EXP) trovafloxacin (ISO) tunicamycin (EXP) urethane (EXP) uridine (ISO) valproic acid (EXP,ISO) zoledronic acid (EXP)
UPP1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 7 48,088,704 - 48,108,736 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 7 48,088,628 - 48,108,736 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 7 48,128,301 - 48,148,333 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 7 48,094,880 - 48,114,855 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 7 48,227,538 - 48,247,515 (+) NCBI Celera Cytogenetic Map 7 p12.3 NCBI HuRef 7 48,013,948 - 48,033,924 (+) NCBI HuRef CHM1_1 7 48,132,055 - 48,152,030 (+) NCBI CHM1_1 T2T-CHM13v2.0 7 48,250,938 - 48,270,970 (+) NCBI T2T-CHM13v2.0 CRA_TCAGchr7v2 7 48,168,224 - 48,188,201 (+) NCBI
Upp1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 9,068,008 - 9,086,170 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 9,068,103 - 9,086,170 (+) Ensembl GRCm39 Ensembl GRCm38 11 9,118,008 - 9,136,170 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 9,118,103 - 9,136,170 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 9,018,011 - 9,036,173 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 9,018,106 - 9,036,167 (+) NCBI MGSCv36 mm8 Celera 11 9,551,715 - 9,569,878 (+) NCBI Celera Cytogenetic Map 11 A1 NCBI cM Map 11 6.13 NCBI
Upp1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 88,023,155 - 88,043,036 (+) NCBI GRCr8 mRatBN7.2 14 83,809,495 - 83,829,299 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 83,809,960 - 83,829,462 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 88,205,103 - 88,223,414 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 89,445,021 - 89,463,332 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 85,912,157 - 85,930,471 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 89,314,234 - 89,334,060 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 89,314,176 - 89,334,276 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 89,112,302 - 89,132,102 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 89,651,264 - 89,669,630 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 89,669,068 - 89,688,775 (+) NCBI Celera 14 82,846,265 - 82,864,631 (+) NCBI Celera Cytogenetic Map 14 q21 NCBI
Upp1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955456 5,365,877 - 5,385,336 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955456 5,365,912 - 5,385,336 (-) NCBI ChiLan1.0 ChiLan1.0
UPP1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 6 52,964,340 - 52,983,714 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 7 101,288,443 - 101,308,447 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 7 48,729,975 - 48,749,598 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 7 48,838,901 - 48,858,189 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 7 48,838,893 - 48,858,185 (+) Ensembl panpan1.1 panPan2
UPP1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 18 108,215 - 120,213 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 18 67,812 - 89,151 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 18 133,593 - 154,855 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 18 133,673 - 164,752 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 18 108,433 - 129,715 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 18 111,361 - 132,570 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 18 246,479 - 267,730 (+) NCBI UU_Cfam_GSD_1.0
Upp1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405118 103,296,840 - 103,319,396 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936478 22,508,559 - 22,531,898 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936478 22,508,602 - 22,531,604 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
UPP1 (Sus scrofa - pig)
UPP1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 21 10,686,600 - 10,707,181 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 21 10,686,093 - 10,706,347 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666062 11,525,130 - 11,545,495 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Upp1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 2652 Count of miRNA genes: 829 Interacting mature miRNAs: 961 Transcripts: ENST00000331803, ENST00000341253, ENST00000395560, ENST00000395564, ENST00000416681, ENST00000417464, ENST00000421046, ENST00000429491, ENST00000432131, ENST00000436673, ENST00000444999, ENST00000457596, ENST00000482015, ENST00000495446 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1558711 BP56_H Blood pressure QTL 56 (human) 2.24 0.000002 Blood pressure systolic 7 36349371 62349371 Human 407048160 GWAS697136_H uridine measurement QTL GWAS697136 (human) 6e-08 uridine measurement 7 48095122 48095123 Human 597280270 GWAS1376344_H 5-methyluridine (ribothymidine) measurement QTL GWAS1376344 (human) 2e-20 5-methyluridine (ribothymidine) measurement 7 48091983 48091984 Human 597280544 GWAS1376618_H uridine measurement QTL GWAS1376618 (human) 5e-21 uridine measurement 7 48089774 48089775 Human 1559132 SAPOB3_H Serum apolipoprotein B level QTL 3 (human) 2 0.4 Apolipoprotein level apolipoprotein B 7 32891074 58891074 Human 597515808 GWAS1611882_H uridine measurement QTL GWAS1611882 (human) 3e-10 uridine measurement 7 48089060 48089061 Human 597436545 GWAS1532619_H uracil measurement QTL GWAS1532619 (human) 1e-10 uracil measurement 7 48102597 48102598 Human 2302781 MAMTS16_H Mammary tumor susceptibility QTL 16 (human) 0.033 Mammary tumor susceptibility 7 36349371 62349371 Human 2289453 BW297_H Body weight QTL 297 (human) 3.83 Body weight body mass index 7 23349464 49349464 Human 597530226 GWAS1626300_H 5-methyluridine (ribothymidine) measurement QTL GWAS1626300 (human) 3e-16 5-methyluridine (ribothymidine) measurement 7 48088961 48088962 Human
WI-11994
Human Assembly Chr Position (strand) Source JBrowse GRCh37 7 48,147,875 - 48,148,002 UniSTS GRCh37 Build 36 7 48,114,400 - 48,114,527 RGD NCBI36 Celera 7 48,247,060 - 48,247,187 RGD Cytogenetic Map 7 p12.3 UniSTS HuRef 7 48,033,469 - 48,033,596 UniSTS CRA_TCAGchr7v2 7 48,187,746 - 48,187,873 UniSTS GeneMap99-GB4 RH Map 7 200.51 UniSTS Whitehead-RH Map 7 173.6 UniSTS
UPP1_7899
Human Assembly Chr Position (strand) Source JBrowse GRCh37 7 48,147,925 - 48,148,486 UniSTS GRCh37 Build 36 7 48,114,450 - 48,115,011 RGD NCBI36 Celera 7 48,247,110 - 48,247,671 RGD HuRef 7 48,033,519 - 48,034,080 UniSTS CRA_TCAGchr7v2 7 48,187,796 - 48,188,357 UniSTS
G35510
Human Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 1 q21 UniSTS Cytogenetic Map 5 q31.2 UniSTS Cytogenetic Map 3 q29 UniSTS Cytogenetic Map 9 q21.13 UniSTS Cytogenetic Map 9 q34.13 UniSTS Cytogenetic Map 17 p13.2 UniSTS Cytogenetic Map 17 q25.1 UniSTS Cytogenetic Map 16 q11.2 UniSTS Cytogenetic Map 14 q24.3 UniSTS Cytogenetic Map 1 q25.1 UniSTS Cytogenetic Map 17 q25 UniSTS Cytogenetic Map 1 q32.3 UniSTS Cytogenetic Map 19 p12 UniSTS Cytogenetic Map 8 p23.1 UniSTS Cytogenetic Map 15 q15.1 UniSTS Cytogenetic Map 1 q42 UniSTS Cytogenetic Map 3 q27.3 UniSTS Cytogenetic Map 7 q21.2 UniSTS Cytogenetic Map 13 q34 UniSTS Cytogenetic Map 19 p13 UniSTS Cytogenetic Map 1 p36.33 UniSTS Cytogenetic Map 20 q13.31 UniSTS Cytogenetic Map 15 q21.3 UniSTS Cytogenetic Map 9 p13.3 UniSTS Cytogenetic Map 5 q35.3 UniSTS Cytogenetic Map 19 p13.11 UniSTS Cytogenetic Map 19 q13.42 UniSTS Cytogenetic Map 10 q21.3 UniSTS Cytogenetic Map 1 p22 UniSTS Cytogenetic Map 14 q32.33 UniSTS Cytogenetic Map 16 p13.3 UniSTS Cytogenetic Map 2 p11.2 UniSTS Cytogenetic Map 7 q11.23 UniSTS Cytogenetic Map 1 p36.1 UniSTS Cytogenetic Map 1 q23.1 UniSTS Cytogenetic Map 6 p21.33 UniSTS Cytogenetic Map 9 q32 UniSTS Cytogenetic Map 1 q42.13 UniSTS Cytogenetic Map 7 q22.1 UniSTS Cytogenetic Map 8 p11.22 UniSTS Cytogenetic Map 19 q13.32 UniSTS Cytogenetic Map 7 p22.2 UniSTS Cytogenetic Map 18 p11.21 UniSTS Cytogenetic Map 22 q13.33 UniSTS Cytogenetic Map 14 q32.12 UniSTS Cytogenetic Map 7 q21.13 UniSTS Cytogenetic Map 1 p32.3 UniSTS Cytogenetic Map 15 q22.2 UniSTS Cytogenetic Map 16 p11.2 UniSTS Cytogenetic Map 13 q12.11 UniSTS Cytogenetic Map 10 p12 UniSTS Cytogenetic Map 9 q13-q21 UniSTS Cytogenetic Map 11 p15.4 UniSTS Cytogenetic Map 4 p16.3 UniSTS Cytogenetic Map 9 q22.3 UniSTS Cytogenetic Map 7 p12.3 UniSTS Cytogenetic Map 1 p34.3 UniSTS Cytogenetic Map 17 p13.3 UniSTS Cytogenetic Map 20 q11.2-q13.2 UniSTS Cytogenetic Map 1 p35.3 UniSTS Cytogenetic Map 2 q36.1 UniSTS Cytogenetic Map 11 q23.3 UniSTS Cytogenetic Map 16 q12.2 UniSTS Cytogenetic Map 5 q35 UniSTS Cytogenetic Map X p22 UniSTS Cytogenetic Map 2 q37.1 UniSTS Cytogenetic Map 2 p25-p24 UniSTS Cytogenetic Map 16 p UniSTS Cytogenetic Map 4 q21.3 UniSTS Cytogenetic Map 19 q13.1 UniSTS Cytogenetic Map 2 q11.2 UniSTS Cytogenetic Map 4 q22.1 UniSTS Cytogenetic Map 7 q36.3 UniSTS Cytogenetic Map 5 q12.3 UniSTS Cytogenetic Map 6 q25.1 UniSTS Cytogenetic Map 14 q11.2 UniSTS Cytogenetic Map 19 q13.4 UniSTS Cytogenetic Map 12 q24.31-q24.32 UniSTS Cytogenetic Map 1 p35 UniSTS Cytogenetic Map 1 p34.2 UniSTS Cytogenetic Map 2 q14.3 UniSTS Cytogenetic Map X p11 UniSTS Cytogenetic Map 1 q21.3 UniSTS Cytogenetic Map 14 q32.31 UniSTS Cytogenetic Map X p11.3 UniSTS Cytogenetic Map 12 q22 UniSTS Cytogenetic Map 12 q15 UniSTS Cytogenetic Map 9 p12 UniSTS Cytogenetic Map 1 p35.1 UniSTS Cytogenetic Map 19 q13.11 UniSTS Cytogenetic Map 7 p14.3 UniSTS Cytogenetic Map 14 q13.2 UniSTS Cytogenetic Map 15 q21 UniSTS Cytogenetic Map 1 p36.31 UniSTS Cytogenetic Map 12 q24.31 UniSTS Cytogenetic Map 6 p21.1 UniSTS Cytogenetic Map 2 q31.1 UniSTS Cytogenetic Map 20 p12.1 UniSTS Cytogenetic Map 6 pter-q22.33 UniSTS Cytogenetic Map 14 q32.2 UniSTS Cytogenetic Map 7 q36.1 UniSTS Cytogenetic Map 2 q32.1 UniSTS Cytogenetic Map 9 q21.33 UniSTS Cytogenetic Map 17 q23.3 UniSTS Cytogenetic Map 10 p13 UniSTS Cytogenetic Map 9 q34.11 UniSTS Cytogenetic Map 11 q14.2-q21 UniSTS Cytogenetic Map 15 q22.31 UniSTS Cytogenetic Map 11 q22-q23 UniSTS Cytogenetic Map 14 q12 UniSTS Cytogenetic Map 1 q25 UniSTS Cytogenetic Map 7 p11.2 UniSTS Cytogenetic Map 4 q13.3 UniSTS Cytogenetic Map 19 p13.2 UniSTS Cytogenetic Map 17 q24.1 UniSTS Cytogenetic Map 14 q21 UniSTS Cytogenetic Map 8 q11.2 UniSTS Cytogenetic Map 3 q28 UniSTS Cytogenetic Map 9 p21.3 UniSTS Cytogenetic Map 7 p15.1 UniSTS Cytogenetic Map 1 q41 UniSTS Cytogenetic Map 8 p21.3 UniSTS Cytogenetic Map 2 q37.3 UniSTS Cytogenetic Map 15 q14-q15 UniSTS Cytogenetic Map 5 q31-q32 UniSTS Cytogenetic Map 18 p11.2 UniSTS Cytogenetic Map 21 q22.11 UniSTS Cytogenetic Map 11 p15.5 UniSTS Cytogenetic Map 13 q14.3 UniSTS Cytogenetic Map 3 p22.2 UniSTS Cytogenetic Map 6 p12.1 UniSTS Cytogenetic Map 6 p21.3 UniSTS Cytogenetic Map 13 q14.11 UniSTS Cytogenetic Map 7 p14.1 UniSTS Cytogenetic Map 19 p13.13 UniSTS Cytogenetic Map 12 p13.33 UniSTS Cytogenetic Map 18 p11.22-p11.21 UniSTS Cytogenetic Map 5 q34-q35 UniSTS Cytogenetic Map 7 q11.21 UniSTS Cytogenetic Map X p11.4 UniSTS Cytogenetic Map 2 p25.3 UniSTS Cytogenetic Map 9 q34 UniSTS Cytogenetic Map 20 q13.12 UniSTS Cytogenetic Map 8 q22.1 UniSTS Cytogenetic Map 16 q24.3 UniSTS Cytogenetic Map 3 q23 UniSTS Cytogenetic Map 12 q23.3 UniSTS Cytogenetic Map 11 q13.1 UniSTS Cytogenetic Map 7 q34 UniSTS Cytogenetic Map 9 q21.11 UniSTS Cytogenetic Map 16 q23.1 UniSTS Cytogenetic Map 17 q24.3 UniSTS Cytogenetic Map 7 p14.2 UniSTS Cytogenetic Map 1 q23.3 UniSTS Cytogenetic Map 9 q34.3 UniSTS Cytogenetic Map 1 p36.2 UniSTS Cytogenetic Map 12 q14.1 UniSTS Cytogenetic Map 19 q13 UniSTS Cytogenetic Map 8 p12 UniSTS Cytogenetic Map 7 p22.1 UniSTS Cytogenetic Map 6 p24.1 UniSTS Cytogenetic Map 6 p21.2 UniSTS Cytogenetic Map 11 q13.4 UniSTS Cytogenetic Map 11 q13.3 UniSTS Cytogenetic Map 1 p33-p32 UniSTS Cytogenetic Map 5 q35.2 UniSTS Cytogenetic Map 3 p14.3 UniSTS Cytogenetic Map 16 p13.2 UniSTS Cytogenetic Map 17 q21.31 UniSTS Cytogenetic Map 10 q26.1 UniSTS Cytogenetic Map 4 q26 UniSTS Cytogenetic Map 12 q13.1-q13.2 UniSTS Cytogenetic Map 1 p36.11 UniSTS Cytogenetic Map 16 q24.1 UniSTS Cytogenetic Map 19 q13.2 UniSTS Cytogenetic Map 3 q13.2 UniSTS Cytogenetic Map 3 p24.3 UniSTS Cytogenetic Map 2 q13 UniSTS Cytogenetic Map 1 q42.3 UniSTS Cytogenetic Map 19 p13.3 UniSTS Cytogenetic Map 17 p13.1 UniSTS Cytogenetic Map X p22.32 UniSTS Cytogenetic Map Y p11.3 UniSTS Cytogenetic Map 20 q13.13 UniSTS Cytogenetic Map 20 q11.21 UniSTS Cytogenetic Map 5 p13.2 UniSTS Cytogenetic Map 6 q13 UniSTS Cytogenetic Map 19 q13.31 UniSTS Cytogenetic Map 18 q11.2 UniSTS Cytogenetic Map 15 q25.2 UniSTS Cytogenetic Map 16 q22.1 UniSTS Cytogenetic Map 20 p13 UniSTS Cytogenetic Map 1 q23.2 UniSTS Cytogenetic Map 15 q15.3 UniSTS Cytogenetic Map 17 q12 UniSTS Cytogenetic Map 15 q13.3 UniSTS Cytogenetic Map X p21.1 UniSTS Cytogenetic Map 19 q13.43 UniSTS Cytogenetic Map 8 q13.1 UniSTS Cytogenetic Map 15 q21.2 UniSTS Cytogenetic Map 6 pter-p12.1 UniSTS Cytogenetic Map 6 p24.3 UniSTS Cytogenetic Map 11 q13.2 UniSTS Cytogenetic Map 13 q14 UniSTS Cytogenetic Map 17 p UniSTS Cytogenetic Map 3 p26 UniSTS Cytogenetic Map 1 p34 UniSTS Cytogenetic Map 12 q13.11 UniSTS Cytogenetic Map 17 q25.3 UniSTS Cytogenetic Map 8 q24.3 UniSTS Cytogenetic Map 17 q23.2 UniSTS Cytogenetic Map 14 q22.3 UniSTS Cytogenetic Map 14 q23.3 UniSTS Cytogenetic Map 20 q13.33 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2438
2788
2253
4970
1726
2350
6
623
1945
465
2269
7299
6465
53
3730
1
852
1744
1616
175
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000331803 ⟹ ENSP00000330032
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,088,644 - 48,108,733 (+) Ensembl
Ensembl Acc Id:
ENST00000395560 ⟹ ENSP00000378927
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,089,265 - 48,108,419 (+) Ensembl
Ensembl Acc Id:
ENST00000395564 ⟹ ENSP00000378931
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,089,265 - 48,108,736 (+) Ensembl
Ensembl Acc Id:
ENST00000416681 ⟹ ENSP00000405209
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,088,628 - 48,103,407 (+) Ensembl
Ensembl Acc Id:
ENST00000417464 ⟹ ENSP00000413611
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,089,376 - 48,108,419 (+) Ensembl
Ensembl Acc Id:
ENST00000421046 ⟹ ENSP00000414963
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,089,227 - 48,103,991 (+) Ensembl
Ensembl Acc Id:
ENST00000432131 ⟹ ENSP00000387607
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,088,661 - 48,099,714 (+) Ensembl
Ensembl Acc Id:
ENST00000436673 ⟹ ENSP00000390118
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,089,265 - 48,103,413 (+) Ensembl
Ensembl Acc Id:
ENST00000444999 ⟹ ENSP00000396820
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,089,282 - 48,107,082 (+) Ensembl
Ensembl Acc Id:
ENST00000457596 ⟹ ENSP00000408899
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,088,727 - 48,108,302 (+) Ensembl
Ensembl Acc Id:
ENST00000482015
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,089,344 - 48,108,419 (+) Ensembl
Ensembl Acc Id:
ENST00000495446
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 7 48,104,646 - 48,108,415 (+) Ensembl
RefSeq Acc Id:
NM_001287426 ⟹ NP_001274355
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,088,704 - 48,108,736 (+) NCBI HuRef 7 48,013,793 - 48,033,924 (+) NCBI CHM1_1 7 48,131,900 - 48,152,030 (+) NCBI T2T-CHM13v2.0 7 48,250,938 - 48,270,970 (+) NCBI
Sequence:
GTCCAGAGAGATCCAGGGTACACACAGTGACAGTGCCAGCTCCACATTCCCGACCACCGGGCCAGGGCTGGTTCCACGCTGTCATTTCTCTCCGCTGGCCCCAGCCGCGGGGCCACCGCCAGACAGAC AGACCGGGGATCCTGCCTGGCGGCGTGACCTTGGGTTAGTCCTAGAGCCGCTTCTAGCCCGGTTTCCTCCGCCCCAGGTTAGGACCACGTGGGGCGGGGCCGCTCGCAGACTCCATATGAGATTCACC TCGCAGGTGGTTCCCTCATTCGAGTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGAGAGCCGTCCCTTCGTCCGGCCCTGGAGCATTGCGTTTGTCGCCGGTGTCGCAGTGCGA GGATGGCGCCGCGGGTGTAGCGGCTCTCTGCGCAGGCCGAGTGGGCTTGGTGAGGTGACTCGCGGTCGCGGGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGT CTGTCCGCCTCCAGCCGCTCTCCTCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAGCCAATGCAGAGAAAGCTGAAAGTCACAATGATTGCCCCGTCAGACTTTTAAATCCAAACAT AGCAAAAATGAAAGAAGATATTCTCTATCATTTCAATCTCACCACTAGCAGACACAATTTCCCAGCCTTGTTTGGAGATGTGAAGTTTGTGTGTGTTGGTGGAAGCCCCTCCCGGATGAAAGCCTTCA TCAGGTGCGTTGGTGCAGAGCTGGGCCTTGACTGCCCAGGTAGAGACTATCCCAACATCTGTGCGGGAACTGACCGCTATGCCATGTATAAAGTAGGACCGGTGCTGTCTGTCAGTCATGGTATGGGC ATTCCTTCTATCTCAATCATGTTGCATGAGCTCATAAAGCTGCTGTACTATGCCCGGTGCTCCAACGTCACTATCATCCGCATTGGCACTTCTGGTGGGATAGGTCTGGAGCCCGGCACTGTGGTCAT AACAGAGCAGGCAGTGGATACCTGCTTCAAGGCAGAGTTTGAGCAGATTGTCCTGGGGAAGCGGGTCATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGC TGAGCGAGTTCACCACAGTGGTGGGGAACACCATGTGCACCTTGGACTTCTATGAAGGGCAAGGCCGTCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCC TATGCAGCCGGCGTCCGCAATATCGAGATGGAGTCCTCGGTGTTTGCCGCCATGTGCAGCGCCTGCGGCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAG CAGCCCTCGCAATGTGCTCAGCGAGTACCAGCAGAGGCCGCAGCGGCTGGTGAGCTACTTCATCAAGAAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTG CCATTAAAAGCATTGTCCAAAATCCCCTGTTGTGTGGACTTTGAGCACACTTTACACAAGAATCTAGAAAATCAGATCGCGATTAAGAGACAGAGAATCTTGGATTAACCGCATGGGAGATGTTCTTC CTTTTGAAGTTTCATTGGAGCATTTTCAATGATGTTAGCCTGATTTGGGGTTTCTTCAAGAACATTCTACCAAATTTTTGTACTATTTCTAGGGAAATTTTTCAGACTTTAAAATTCTAATGGTAGTC AGATTTCATGTCACTAAACAAGAAATCTGACAATAGTGCCAGGAAACTAATTTCCTGATACATTAAAAAAATTCCATGCACCA
hide sequence
RefSeq Acc Id:
NM_001287428 ⟹ NP_001274357
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,088,704 - 48,108,736 (+) NCBI HuRef 7 48,013,793 - 48,033,924 (+) NCBI CHM1_1 7 48,131,900 - 48,152,030 (+) NCBI T2T-CHM13v2.0 7 48,250,938 - 48,270,970 (+) NCBI
Sequence:
GTCCAGAGAGATCCAGGGTACACACAGTGACAGTGCCAGCTCCACATTCCCGACCACCGGGCCAGGGCTGGTTCCACGCTGTCATTTCTCTCCGCTGGCCCCAGCCGCGGGGCCACCGCCAGACAGAC AGACCGGGGATCCTGCCTGGCGGCGTGACCTTGGGTTAGTCCTAGAGCCGCTTCTAGCCCGGTTTCCTCCGCCCCAGTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGAGAGCC GTCCCTTCGTCCGGCCCTGGAGCATTGCGTTTGTCGCCGGTGTCGCAGTGCGAGGATGGCGCCGCGGGTGTAGCGGCTCTCTGCGCAGGCCGAGTGGGCCCAGAGAAGCGAGGAACTCCGCAGCTCGT CGACACGTCTCGTCTCCTGTCCCAATTCAGGGCTTGGTGAGGTGACTCGCGGTCGCGGGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCA GCCGCTCTCCTCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAGCCAATGCAGAGAAAGCTGAAAGTCACAAGTCTGGAGCCCGGCACTGTGGTCATAACAGAGCAGGCAGTGGATAC CTGCTTCAAGGCAGAGTTTGAGCAGATTGTCCTGGGGAAGCGGGTCATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGCTGAGCGAGTTCACCACAGTGG TGGGGAACACCATGTGCACCTTGGACTTCTATGAAGGGCAAGGCCGTCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCCTATGCAGCCGGCGTCCGCAAT ATCGAGATGGAGTCCTCGGTGTTTGCCGCCATGTGCAGCGCCTGCGGCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAGCAGCCCTCGCAATGTGCTCAG CGAGTACCAGCAGAGGCCGCAGCGGCTGGTGAGCTACTTCATCAAGAAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTGCCATTAAAAGCATTGTCCAAA ATCCCCTGTTGTGTGGACTTTGAGCACACTTTACACAAGAATCTAGAAAATCAGATCGCGATTAAGAGACAGAGAATCTTGGATTAACCGCATGGGAGATGTTCTTCCTTTTGAAGTTTCATTGGAGC ATTTTCAATGATGTTAGCCTGATTTGGGGTTTCTTCAAGAACATTCTACCAAATTTTTGTACTATTTCTAGGGAAATTTTTCAGACTTTAAAATTCTAATGGTAGTCAGATTTCATGTCACTAAACAA GAAATCTGACAATAGTGCCAGGAAACTAATTTCCTGATACATTAAAAAAATTCCATGCACCA
hide sequence
RefSeq Acc Id:
NM_001287429 ⟹ NP_001274358
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,265 - 48,108,736 (+) NCBI HuRef 7 48,013,793 - 48,033,924 (+) NCBI CHM1_1 7 48,132,437 - 48,152,030 (+) NCBI T2T-CHM13v2.0 7 48,251,499 - 48,270,970 (+) NCBI
Sequence:
ATTCGAGTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGAGAGCCGTCCCT TCGTCCGGCCCTGGAGCATTGCGTTTGTCGCCGGTGTCGCAGTGCGAGGATGGCGCCGCGGGTGTAGCGGCTCTCTGCGCAGGCCGAGTGGGCCCAGAGAAGCGAGGAACTCCGCAGCTCGTCGACAC GTCTCGTCTCCTGTCCCAATTCAGGGCTTGGTGAGGTGACTCGCGGTCGCGGGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCAGCCGCT CTCCTCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAGCCAATGCAGAGAAAGCTGAAAGTCACAAGTCTGGAGCCCGGCACTGTGGTCATAACAGAGCAGGCAGTGGATACCTGCTT CAAGGCAGAGTTTGAGCAGATTGTCCTGGGGAAGCGGGTCATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGCTGAGCGAGTTCACCACAGTGGTGGGGA ACACCATGTGCACCTTGGACTTCTATGAAGGGCAAGGCCGTCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCCTATGCAGCCGGCGTCCGCAATATCGAG ATGGAGTCCTCGGTGTTTGCCGCCATGTGCAGCGCCTGCGGCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAGCAGCCCTCGCAATGTGCTCAGCGAGTA CCAGCAGAGGCCGCAGCGGCTGGTGAGCTACTTCATCAAGAAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTGCCATTAAAAGCATTGTCCAAAATCCCC TGTTGTGTGGACTTTGAGCACACTTTACACAAGAATCTAGAAAATCAGATCGCGATTAAGAGACAGAGAATCTTGGATTAACCGCATGGGAGATGTTCTTCCTTTTGAAGTTTCATTGGAGCATTTTC AATGATGTTAGCCTGATTTGGGGTTTCTTCAAGAACATTCTACCAAATTTTTGTACTATTTCTAGGGAAATTTTTCAGACTTTAAAATTCTAATGGTAGTCAGATTTCATGTCACTAAACAAGAAATC TGACAATAGTGCCAGGAAACTAATTTCCTGATACATTAAAAAAATTCCATGCACCA
hide sequence
RefSeq Acc Id:
NM_001287430 ⟹ NP_001274359
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,254 - 48,108,733 (+) NCBI HuRef 7 48,013,793 - 48,033,924 (+) NCBI CHM1_1 7 48,132,551 - 48,152,030 (+) NCBI T2T-CHM13v2.0 7 48,251,488 - 48,270,967 (+) NCBI
Sequence:
GTGGTTCCCTCATTCGAGTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGA GAGCCGTCCCTTCGTCCGGCCCTGGAGCATTGCGTTTGTCGCCGGTGTCGCAGTGCGAGGATGGCGCCGCGGGTGTAGCGGCTCTCTGCGCAGGCCGAGTGGGCTTGGTGAGGTGACTCGCGGTCGCG GGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCAGCCGCTCTCCTCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAGCCA ATGCAGAGAAAGCTGAAAGTCACAAGTCTGGAGCCCGGCACTGTGGTCATAACAGAGCAGGCAGTGGATACCTGCTTCAAGGCAGAGTTTGAGCAGATTGTCCTGGGGAAGCGGGTCATCCGGAAAAC GGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGCTGAGCGAGTTCACCACAGTGGTGGGGAACACCATGTGCACCTTGGACTTCTATGAAGGGCAAGGCCGTCTGGATGGGG CTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCCTATGCAGCCGGCGTCCGCAATATCGAGATGGAGTCCTCGGTGTTTGCCGCCATGTGCAGCGCCTGCGGCCTCCAAGCG GCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAGCAGCCCTCGCAATGTGCTCAGCGAGTACCAGCAGAGGCCGCAGCGGCTGGTGAGCTACTTCATCAAGAAGAAACTGAG CAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTGCCATTAAAAGCATTGTCCAAAATCCCCTGTTGTGTGGACTTTGAGCACACTTTACACAAGAATCTAGAAAATCAGATC GCGATTAAGAGACAGAGAATCTTGGATTAACCGCATGGGAGATGTTCTTCCTTTTGAAGTTTCATTGGAGCATTTTCAATGATGTTAGCCTGATTTGGGGTTTCTTCAAGAACATTCTACCAAATTTT TGTACTATTTCTAGGGAAATTTTTCAGACTTTAAAATTCTAATGGTAGTCAGATTTCATGTCACTAAACAAGAAATCTGACAATAGTGCCAGGAAACTAATTTCCTGATACATTAAAAAAATTCCATG CAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NM_001362774 ⟹ NP_001349703
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,088,704 - 48,108,736 (+) NCBI T2T-CHM13v2.0 7 48,250,938 - 48,270,970 (+) NCBI
Sequence:
GTCCAGAGAGATCCAGGGTACACACAGTGACAGTGCCAGCTCCACATTCCCGACCACCGGGCCA GGGCTGGTTCCACGCTGTCATTTCTCTCCGCTGGCCCCAGCCGCGGGGCCACCGCCAGACAGACAGACCGGGGATCCTGCCTGGCGGCGTGACCTTGGGTTAGTCCTAGAGCCGCTTCTAGCCCGGTT TCCTCCGCCCCAGGTTAGGACCACGTGGGTGGTTCCCTCATTCGAGTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGAGAGCCGTCCCTTCGTCCGGCCCTGGAGCATTGCGTT TGTCGCCGGTGTCGCAGTGCGAGGATGGCGCCGCGGGTGTAGCGGCTCTCTGCGCAGGCCGAGTGGGCCCAGAGAAGCGAGGAACTCCGCAGCTCGTCGACACGTCTCGTCTCCTGTCCCAATTCAGG GCTTGGTGAGGTGACTCGCGGTCGCGGGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCAGCCGCTCTCCTCTGACGGGTCCTGCCTCAGT TGGCGGAATGGCGGCCACGGGAGCCAATGCAGAGAAAGCTGAAAGTCACAATGATTGCCCCGTCAGACTTTTAAATCCAAACATAGCAAAAATGAAAGAAGATATTCTCTATCATTTCAATCTCACCA CTAGCAGACACAATTTCCCAGCCTTGTTTGGAGATGTGAAGTTTGTGTGTGTTGGTGGAAGCCCCTCCCGGATGAAAGCCTTCATCAGGTGCGTTGGTGCAGAGCTGGGCCTTGACTGCCCAGGTAGA GACTATCCCAACATCTGTGCGGGAACTGACCGCTATGCCATGTATAAAGTAGGACCGGTGCTGTCTGTCAGTCATGGTATGGGCATTCCTTCTATCTCAATCATGTTGCATGAGCTCATAAAGCTGCT GTACTATGCCCGGTGCTCCAACGTCACTATCATCCGCATTGGCACTTCTGGTGGGATAGGTCTGGAGCCCGGCACTGTGGTCATAACAGAGCAGGCAGTGGATACCTGCTTCAAGGCAGAGTTTGAGC AGATTGTCCTGGGGAAGCGGGTCATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGCTGAGCGAGTTCACCACAGTGGTGGGGAACACCATGTGCACCTTG GACTTCTATGAAGGGCAAGGCCGTCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCCTATGCAGCCGGCGTCCGCAATATCGAGATGGAGTCCTCGGTGTT TGCCGCCATGTGCAGCGCCTGCGGCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAGCAGCCCTCGCAATGTGCTCAGCGAGTACCAGCAGAGGCCGCAGC GGCTGGTGAGCTACTTCATCAAGAAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTGCCATTAAAAGCATTGTCCAAAATCCCCTGTTGTGTGGACTTTGA GCACACTTTACACAAGAATCTAGAAAATCAGATCGCGATTAAGAGACAGAGAATCTTGGATTAACCGCATGGGAGATGTTCTTCCTTTTGAAGTTTCATTGGAGCATTTTCAATGATGTTAGCCTGAT TTGGGGTTTCTTCAAGAACATTCTACCAAATTTTTGTACTATTTCTAGGGAAATTTTTCAGACTTTAAAATTCTAATGGTAGTCAGATTTCATGTCACTAAACAAGAAATCTGACAATAGTGCCAGGA AACTAATTTCCTGATACATTAAAAAAATTCCATGCACCA
hide sequence
RefSeq Acc Id:
NM_003364 ⟹ NP_003355
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,265 - 48,108,736 (+) NCBI GRCh37 7 48,128,355 - 48,148,330 (+) NCBI Build 36 7 48,095,271 - 48,114,855 (+) NCBI Archive HuRef 7 48,013,793 - 48,033,924 (+) NCBI CHM1_1 7 48,132,509 - 48,152,030 (+) NCBI T2T-CHM13v2.0 7 48,251,499 - 48,270,970 (+) NCBI CRA_TCAGchr7v2 7 48,168,224 - 48,188,201 (+) ENTREZGENE
Sequence:
ATTCGAGTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGAGAGCCGTCCCT TCGTCCGGCCCTGGAGCATTGCGTTTGTCGCCGGTGTCGCAGTGCGAGGATGGCGCCGCGGGTGTAGCGGCTCTCTGCGCAGGCCGAGTGGGCCCAGAGAAGCGAGGAACTCCGCAGCTCGTCGACAC GTCTCGTCTCCTGTCCCAATTCAGGGCTTGGTGAGGTGACTCGCGGTCGCGGGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCAGCCGCT CTCCTCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAGCCAATGCAGAGAAAGCTGAAAGTCACAATGATTGCCCCGTCAGACTTTTAAATCCAAACATAGCAAAAATGAAAGAAGAT ATTCTCTATCATTTCAATCTCACCACTAGCAGACACAATTTCCCAGCCTTGTTTGGAGATGTGAAGTTTGTGTGTGTTGGTGGAAGCCCCTCCCGGATGAAAGCCTTCATCAGGTGCGTTGGTGCAGA GCTGGGCCTTGACTGCCCAGGTAGAGACTATCCCAACATCTGTGCGGGAACTGACCGCTATGCCATGTATAAAGTAGGACCGGTGCTGTCTGTCAGTCATGGTATGGGCATTCCTTCTATCTCAATCA TGTTGCATGAGCTCATAAAGCTGCTGTACTATGCCCGGTGCTCCAACGTCACTATCATCCGCATTGGCACTTCTGGTGGGATAGGTCTGGAGCCCGGCACTGTGGTCATAACAGAGCAGGCAGTGGAT ACCTGCTTCAAGGCAGAGTTTGAGCAGATTGTCCTGGGGAAGCGGGTCATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGCTGAGCGAGTTCACCACAGT GGTGGGGAACACCATGTGCACCTTGGACTTCTATGAAGGGCAAGGCCGTCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCCTATGCAGCCGGCGTCCGCA ATATCGAGATGGAGTCCTCGGTGTTTGCCGCCATGTGCAGCGCCTGCGGCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAGCAGCCCTCGCAATGTGCTC AGCGAGTACCAGCAGAGGCCGCAGCGGCTGGTGAGCTACTTCATCAAGAAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTGCCATTAAAAGCATTGTCCA AAATCCCCTGTTGTGTGGACTTTGAGCACACTTTACACAAGAATCTAGAAAATCAGATCGCGATTAAGAGACAGAGAATCTTGGATTAACCGCATGGGAGATGTTCTTCCTTTTGAAGTTTCATTGGA GCATTTTCAATGATGTTAGCCTGATTTGGGGTTTCTTCAAGAACATTCTACCAAATTTTTGTACTATTTCTAGGGAAATTTTTCAGACTTTAAAATTCTAATGGTAGTCAGATTTCATGTCACTAAAC AAGAAATCTGACAATAGTGCCAGGAAACTAATTTCCTGATACATTAAAAAAATTCCATGCACCA
hide sequence
RefSeq Acc Id:
NR_109837
RefSeq Status:
REVIEWED
Type:
NON-CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,254 - 48,108,733 (+) NCBI HuRef 7 48,013,793 - 48,033,924 (+) NCBI CHM1_1 7 48,132,551 - 48,152,030 (+) NCBI T2T-CHM13v2.0 7 48,251,488 - 48,270,967 (+) NCBI
Sequence:
GTGGTTCCCTCATTCGAGTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGA GAGCCGTCCCTTCGTCCGGCCCTGGAGCATTGCGTTTGTCGCCGGTGTCGCAGTGCGAGGATGGCGCCGCGGGTGTAGCGGCTCTCTGCGCAGGCCGAGTGGGCTTGGTGAGGTGACTCGCGGTCGCG GGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCAGCCGCTCTCCTCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAGCCA ATGCAGAGAAAGCTGAAAGTCACAATTTGTGTGTGTTGGTGGAAGCCCCTCCCGGATGAAAGCCTTCATCAGGTCTGGAGCCCGGCACTGTGGTCATAACAGAGCAGGCAGTGGATACCTGCTTCAAG GCAGAGTTTGAGCAGATTGTCCTGGGGAAGCGGGTCATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGCTGAGCGAGTTCACCACAGTGGTGGGGAACAC CATGTGCACCTTGGACTTCTATGAAGGGCAAGGCCGTCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCCTATGCAGCCGGCGTCCGCAATATCGAGATGG AGTCCTCGGTGTTTGCCGCCATGTGCAGCGCCTGCGGCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAGCAGCCCTCGCAATGTGCTCAGCGAGTACCAG CAGAGGCCGCAGCGGCTGGTGAGCTACTTCATCAAGAAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTGCCATTAAAAGCATTGTCCAAAATCCCCTGTT GTGTGGACTTTGAGCACACTTTACACAAGAATCTAGAAAATCAGATCGCGATTAAGAGACAGAGAATCTTGGATTAACCGCATGGGAGATGTTCTTCCTTTTGAAGTTTCATTGGAGCATTTTCAATG ATGTTAGCCTGATTTGGGGTTTCTTCAAGAACATTCTACCAAATTTTTGTACTATTTCTAGGGAAATTTTTCAGACTTTAAAATTCTAATGGTAGTCAGATTTCATGTCACTAAACAAGAAATCTGAC AATAGTGCCAGGAAACTAATTTCCTGATACATTAAAAAAATTCCATGCAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_011515512 ⟹ XP_011513814
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,088,704 - 48,108,736 (+) NCBI
Sequence:
CAGGCGTGAGCCACCACTCCCGGCCCAACCCCATGTTTTCTCAGGAACTGGAGTTCCCTTTAGGAAGCAAGTAACAGAGGTGCTGGGCTGCCCGGGCCTCTAGGTCGTCTTCTTTCCCAGGCTCTGTG CTCTCACCAGAGTGCGCGTTCGGGAAGCAGGGAGAGGACCAGGAAAGACGCCTGAGACGGAGAGTGGGCACCGGCCGGGGGCAGGCAGGTCCGGCCCCTGGGGGTCAGAGTGCAGCGCCGGTTTGAGG CAGTTCGGCCACTTAGCTGCGACTCGAAGTGAATGAGTCACTTCCCCTCCTCGGGCGAGCTCCTGGCTTTGCCCCAGCAAGCGGGAACTCCCAGGATCAGGAAGGTCCCAGAGAAACTCCCCAGGGGG GAAGCCGAGGCCGTCCAGAGAGATCCAGGGTACACACAGTGACAGTGCCAGCTCCACATTCCCGACCACCGGGCCAGGGCTGGTTCCACGCTGTCATTTCTCTCCGCTGGCCCCAGCCGCGGGGCCAC CGCCAGACAGACAGACCGGGGATCCTGCCTGGCGGCGTGACCTTGGGTTAGTCCTAGAGCCGCTTCTAGCCCGGTTTCCTCCGCCCCAGGTTAGGACCACGTGGGGCTTGGTGAGGTGACTCGCGGTC GCGGGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCAGCCGCTCTCCTCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAG CCAATGCAGAGAAAGCTGAAAGTCACAATGATTGCCCCGTCAGACTTTTAAATCCAAACATAGCAAAAATGAAAGAAGATATTCTCTATCATTTCAATCTCACCACTAGCAGACACAATTTCCCAGCC TTGTTTGGAGATGTGAAGTTTGTGTGTGTTGGTGGAAGCCCCTCCCGGATGAAAGCCTTCATCAGGTGCGTTGGTGCAGAGCTGGGCCTTGACTGCCCAGGTAGAGACTATCCCAACATCTGTGCGGG AACTGACCGCTATGCCATGTATAAAGTAGGACCGGTGCTGTCTGTCAGTCATGGTATGGGCATTCCTTCTATCTCAATCATGTTGCATGAGCTCATAAAGCTGCTGTACTATGCCCGGTGCTCCAACG TCACTATCATCCGCATTGGCACTTCTGGTGGGATAGGTCTGGAGCCCGGCACTGTGGTCATAACAGAGCAGGCAGTGGATACCTGCTTCAAGGCAGAGTTTGAGCAGATTGTCCTGGGGAAGCGGGTC ATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGCTGAGCGAGTTCACCACAGTGGTGGGGAACACCATGTGCACCTTGGACTTCTATGAAGGGCAAGGCCG TCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCCTATGCAGCCGGCGTCCGCAATATCGAGATGGAGTCCTCGGTGTTTGCCGCCATGTGCAGCGCCTGCG GCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAGCAGCCCTCGCAATGTGCTCAGCGAGTACCAGCAGAGGCCGCAGCGGCTGGTGAGCTACTTCATCAAG AAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTGCCATTAAAAGCATTGTCCAAAATC
hide sequence
RefSeq Acc Id:
XM_011515513 ⟹ XP_011513815
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,212 - 48,108,736 (+) NCBI
Sequence:
GGATGCGGTCAGCTGAGTTCGCCGGCCCAGGGCAGGCGGGGCCCGAGCCTAGCGGTAACCCCCGGGCAGGGCGGGGCCGCTCGCAGACTCCATATGAGATTCACCTCGCAGGTGGTTCCCTCATTCGA GTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGAGAGCCGTCCCTTCGTCCGGCCCTGGAGCATTGCGTTTGTCGCCGGTGTCGCAGTGCGAGGATGGCGCCGCGGGTGTAGCGG CTCTCTGCGCAGGCCGAGTGGGCCCAGAGAAGCGAGGAACTCCGCAGCTCGTCGACACGTCTCGTCTCCTGTCCCAATTCAGGGCTTGGTGAGGTGACTCGCGGTCGCGGGTGACTCGCCGGCAGGAC ACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCAGCCGCTCTCCTCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAGCCAATGCAGAGAAAGCTGAAAG TCACAATTTGTGTGTGTTGGTGGAAGCCCCTCCCGGATGAAAGCCTTCATCAGCATGGTATGGGCATTCCTTCTATCTCAATCATGTTGCATGAGCTCATAAAGCTGCTGTACTATGCCCGGTGCTCC AACGTCACTATCATCCGCATTGGCACTTCTGGTGGGATAGGTCTGGAGCCCGGCACTGTGGTCATAACAGAGCAGGCAGTGGATACCTGCTTCAAGGCAGAGTTTGAGCAGATTGTCCTGGGGAAGCG GGTCATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAGAGCTGAGCGAGTTCACCACAGTGGTGGGGAACACCATGTGCACCTTGGACTTCTATGAAGGGCAAG GCCGTCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCAGCCTATGCAGCCGGCGTCCGCAATATCGAGATGGAGTCCTCGGTGTTTGCCGCCATGTGCAGCGCC TGCGGCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGATCAGCAGCCCTCGCAATGTGCTCAGCGAGTACCAGCAGAGGCCGCAGCGGCTGGTGAGCTACTTCAT CAAGAAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGACTTGCCATTAAAAGCATTGTCCAAAATCC
hide sequence
RefSeq Acc Id:
XM_011515514 ⟹ XP_011513816
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,212 - 48,108,736 (+) NCBI
Sequence:
GGATGCGGTCAGCTGAGTTCGCCGGCCCAGGGCAGGCGGGGCCCGAGCCTAGCGGTAACCCCCGGGCAGGGCGGGGCCGCTCGCAGACTCCATATGAGATTCACCTCGCAGGTGGTTCCCTCATTCGA GTGCTCCGGCGCACAGACCCGCGCCCCGCCGTCTGCGAGCCTCCCGAGAGCCGTCCCTTCGTCCGGCCCTGGAGCATTGCGTTTGTCGCCGGTGTCGCAGTGCGAGGATGGCGCCGCGGGTGTAGCGG CTCTCTGCGCAGGCCGAGTGGGCTTGGTGAGGTGACTCGCGGTCGCGGGTGACTCGCCGGCAGGACACTGCCTGGAACGCCTGGAGCGCCTCCCACTGCAGACGTCTGTCCGCCTCCAGCCGCTCTCC TCTGACGGGTCCTGCCTCAGTTGGCGGAATGGCGGCCACGGGAGCCAATGCAGAGAAAGCTGAAAGTCACAATTTGTGTGTGTTGGTGGAAGCCCCTCCCGGATGAAAGCCTTCATCAGCATGGTATG GGCATTCCTTCTATCTCAATCATGTTGCATGAGCTCATAAAGCTGCTGTACTATGCCCGGTGCTCCAACGTCACTATCATCCGCATTGGCACTTCTGGTGGGATAGGTCTGGAGCCCGGCACTGTGGT CATAACAGAGCAGGCAGTGGATACCTGCTTCAAGGCAGAGTTTGAGCAGATTGTCCTGGGGAAGCGGGTCATCCGGAAAACGGACCTTAACAAGAAGCTGGTGCAGGAGCTGTTGCTGTGTTCTGCAG AGCTGAGCGAGTTCACCACAGTGGTGGGGAACACCATGTGCACCTTGGACTTCTATGAAGGGCAAGGCCGTCTGGATGGGGCTCTCTGCTCCTACACGGAGAAGGACAAGCAGGCGTATCTGGAGGCA GCCTATGCAGCCGGCGTCCGCAATATCGAGATGGAGTCCTCGGTGTTTGCCGCCATGTGCAGCGCCTGCGGCCTCCAAGCGGCCGTGGTGTGTGTCACCCTCCTGAACCGCCTGGAAGGGGACCAGAT CAGCAGCCCTCGCAATGTGCTCAGCGAGTACCAGCAGAGGCCGCAGCGGCTGGTGAGCTACTTCATCAAGAAGAAACTGAGCAAGGCCTGAGCGCTGCCCTGCACCTCCGCAGACCTGCTGTGATGAC TTGCCATTAAAAGCATTGTCCAAAATCC
hide sequence
RefSeq Acc Id:
XM_047420797 ⟹ XP_047276753
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,212 - 48,108,736 (+) NCBI
RefSeq Acc Id:
XM_047420798 ⟹ XP_047276754
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,212 - 48,104,267 (+) NCBI
RefSeq Acc Id:
XM_047420799 ⟹ XP_047276755
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 7 48,089,212 - 48,104,267 (+) NCBI
RefSeq Acc Id:
XM_054358929 ⟹ XP_054214904
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 7 48,250,938 - 48,270,970 (+) NCBI
RefSeq Acc Id:
XM_054358930 ⟹ XP_054214905
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 7 48,251,446 - 48,270,970 (+) NCBI
RefSeq Acc Id:
XM_054358931 ⟹ XP_054214906
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 7 48,251,446 - 48,270,970 (+) NCBI
RefSeq Acc Id:
XM_054358932 ⟹ XP_054214907
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 7 48,251,446 - 48,270,970 (+) NCBI
RefSeq Acc Id:
XM_054358933 ⟹ XP_054214908
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 7 48,251,446 - 48,268,436 (+) NCBI
RefSeq Acc Id:
XM_054358934 ⟹ XP_054214909
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 7 48,251,446 - 48,268,436 (+) NCBI
RefSeq Acc Id:
NP_003355 ⟸ NM_003364
- Peptide Label:
isoform a
- UniProtKB:
D3DVM4 (UniProtKB/Swiss-Prot), Q15362 (UniProtKB/Swiss-Prot), Q16831 (UniProtKB/Swiss-Prot)
- Sequence:
MAATGANAEKAESHNDCPVRLLNPNIAKMKEDILYHFNLTTSRHNFPALFGDVKFVCVGGSPSRMKAFIRCVGAELGLDCPGRDYPNICAGTDRYAMYKVGPVLSVSHGMGIPSISIMLHELIKLLYY ARCSNVTIIRIGTSGGIGLEPGTVVITEQAVDTCFKAEFEQIVLGKRVIRKTDLNKKLVQELLLCSAELSEFTTVVGNTMCTLDFYEGQGRLDGALCSYTEKDKQAYLEAAYAAGVRNIEMESSVFAA MCSACGLQAAVVCVTLLNRLEGDQISSPRNVLSEYQQRPQRLVSYFIKKKLSKA
hide sequence
RefSeq Acc Id:
NP_001274355 ⟸ NM_001287426
- Peptide Label:
isoform a
- UniProtKB:
D3DVM4 (UniProtKB/Swiss-Prot), Q15362 (UniProtKB/Swiss-Prot), Q16831 (UniProtKB/Swiss-Prot)
- Sequence:
MAATGANAEKAESHNDCPVRLLNPNIAKMKEDILYHFNLTTSRHNFPALFGDVKFVCVGGSPSR MKAFIRCVGAELGLDCPGRDYPNICAGTDRYAMYKVGPVLSVSHGMGIPSISIMLHELIKLLYYARCSNVTIIRIGTSGGIGLEPGTVVITEQAVDTCFKAEFEQIVLGKRVIRKTDLNKKLVQELLL CSAELSEFTTVVGNTMCTLDFYEGQGRLDGALCSYTEKDKQAYLEAAYAAGVRNIEMESSVFAAMCSACGLQAAVVCVTLLNRLEGDQISSPRNVLSEYQQRPQRLVSYFIKKKLSKA
hide sequence
RefSeq Acc Id:
NP_001274357 ⟸ NM_001287428
- Peptide Label:
isoform b
- UniProtKB:
Q86Y75 (UniProtKB/TrEMBL)
- Sequence:
MQRKLKVTSLEPGTVVITEQAVDTCFKAEFEQIVLGKRVIRKTDLNKKLVQELLLCSAELSEFTTVVGNTMCTLDFYEGQGRLDGALCSYTEKDKQAYLEAAYAAGVRNIEMESSVFAAMCSACGLQA AVVCVTLLNRLEGDQISSPRNVLSEYQQRPQRLVSYFIKKKLSKA
hide sequence
RefSeq Acc Id:
NP_001274358 ⟸ NM_001287429
- Peptide Label:
isoform b
- UniProtKB:
Q86Y75 (UniProtKB/TrEMBL)
- Sequence:
MQRKLKVTSLEPGTVVITEQAVDTCFKAEFEQIVLGKRVIRKTDLNKKLVQELLLCSAELSEFT TVVGNTMCTLDFYEGQGRLDGALCSYTEKDKQAYLEAAYAAGVRNIEMESSVFAAMCSACGLQAAVVCVTLLNRLEGDQISSPRNVLSEYQQRPQRLVSYFIKKKLSKA
hide sequence
RefSeq Acc Id:
NP_001274359 ⟸ NM_001287430
- Peptide Label:
isoform b
- UniProtKB:
Q86Y75 (UniProtKB/TrEMBL)
- Sequence:
MQRKLKVTSLEPGTVVITEQAVDTCFKAEFEQIVLGKRVIRKTDLNKKLVQELLLCSAELSEFTTVVGNTMCTLDFYEGQGRLDGALCSYTEKDKQAYLEAAYAAGVRNIEMESSVFAAMCSACGLQA AVVCVTLLNRLEGDQISSPRNVLSEYQQRPQRLVSYFIKKKLSKA
hide sequence
RefSeq Acc Id:
XP_011513814 ⟸ XM_011515512
- Peptide Label:
isoform X1
- UniProtKB:
D3DVM4 (UniProtKB/Swiss-Prot), Q15362 (UniProtKB/Swiss-Prot), Q16831 (UniProtKB/Swiss-Prot)
- Sequence:
MAATGANAEKAESHNDCPVRLLNPNIAKMKEDILYHFNLTTSRHNFPALFGDVKFVCVGGSPSR MKAFIRCVGAELGLDCPGRDYPNICAGTDRYAMYKVGPVLSVSHGMGIPSISIMLHELIKLLYYARCSNVTIIRIGTSGGIGLEPGTVVITEQAVDTCFKAEFEQIVLGKRVIRKTDLNKKLVQELLL CSAELSEFTTVVGNTMCTLDFYEGQGRLDGALCSYTEKDKQAYLEAAYAAGVRNIEMESSVFAAMCSACGLQAAVVCVTLLNRLEGDQISSPRNVLSEYQQRPQRLVSYFIKKKLSKA
hide sequence
RefSeq Acc Id:
XP_011513815 ⟸ XM_011515513
- Peptide Label:
isoform X3
- Sequence:
MQRKLKVTICVCWWKPLPDESLHQHGMGIPSISIMLHELIKLLYYARCSNVTIIRIGTSGGIGLEPGTVVITEQAVDTCFKAEFEQIVLGKRVIRKTDLNKKLVQELLLCSAELSEFTTVVGNTMCTL DFYEGQGRLDGALCSYTEKDKQAYLEAAYAAGVRNIEMESSVFAAMCSACGLQAAVVCVTLLNRLEGDQISSPRNVLSEYQQRPQRLVSYFIKKKLSKA
hide sequence
RefSeq Acc Id:
XP_011513816 ⟸ XM_011515514
- Peptide Label:
isoform X3
- Sequence:
MQRKLKVTICVCWWKPLPDESLHQHGMGIPSISIMLHELIKLLYYARCSNVTIIRIGTSGGIGLEPGTVVITEQAVDTCFKAEFEQIVLGKRVIRKTDLNKKLVQELLLCSAELSEFTTVVGNTMCTL DFYEGQGRLDGALCSYTEKDKQAYLEAAYAAGVRNIEMESSVFAAMCSACGLQAAVVCVTLLNRLEGDQISSPRNVLSEYQQRPQRLVSYFIKKKLSKA
hide sequence
RefSeq Acc Id:
NP_001349703 ⟸ NM_001362774
- Peptide Label:
isoform a
- UniProtKB:
Q16831 (UniProtKB/Swiss-Prot), D3DVM4 (UniProtKB/Swiss-Prot), Q15362 (UniProtKB/Swiss-Prot)
Ensembl Acc Id:
ENSP00000330032 ⟸ ENST00000331803
Ensembl Acc Id:
ENSP00000405209 ⟸ ENST00000416681
Ensembl Acc Id:
ENSP00000413611 ⟸ ENST00000417464
Ensembl Acc Id:
ENSP00000408899 ⟸ ENST00000457596
Ensembl Acc Id:
ENSP00000396820 ⟸ ENST00000444999
Ensembl Acc Id:
ENSP00000387607 ⟸ ENST00000432131
Ensembl Acc Id:
ENSP00000378931 ⟸ ENST00000395564
Ensembl Acc Id:
ENSP00000378927 ⟸ ENST00000395560
Ensembl Acc Id:
ENSP00000414963 ⟸ ENST00000421046
Ensembl Acc Id:
ENSP00000390118 ⟸ ENST00000436673
RefSeq Acc Id:
XP_047276753 ⟸ XM_047420797
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_047276754 ⟸ XM_047420798
- Peptide Label:
isoform X4
- UniProtKB:
C9JIP2 (UniProtKB/TrEMBL), B4DND0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_047276755 ⟸ XM_047420799
- Peptide Label:
isoform X4
- UniProtKB:
C9JIP2 (UniProtKB/TrEMBL), B4DND0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054214904 ⟸ XM_054358929
- Peptide Label:
isoform X1
- UniProtKB:
Q16831 (UniProtKB/Swiss-Prot), D3DVM4 (UniProtKB/Swiss-Prot), Q15362 (UniProtKB/Swiss-Prot)
RefSeq Acc Id:
XP_054214906 ⟸ XM_054358931
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_054214905 ⟸ XM_054358930
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_054214907 ⟸ XM_054358932
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_054214908 ⟸ XM_054358933
- Peptide Label:
isoform X4
- UniProtKB:
C9JIP2 (UniProtKB/TrEMBL), B4DND0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054214909 ⟸ XM_054358934
- Peptide Label:
isoform X4
- UniProtKB:
C9JIP2 (UniProtKB/TrEMBL), B4DND0 (UniProtKB/TrEMBL)
RGD ID: 7210573
Promoter ID: EPDNEW_H11032
Type: initiation region
Name: UPP1_2
Description: uridine phosphorylase 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H11033 EPDNEW_H11034
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 7 48,088,708 - 48,088,768 EPDNEW
RGD ID: 7210575
Promoter ID: EPDNEW_H11033
Type: initiation region
Name: UPP1_1
Description: uridine phosphorylase 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H11032 EPDNEW_H11034
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 7 48,089,265 - 48,089,325 EPDNEW
RGD ID: 7210577
Promoter ID: EPDNEW_H11034
Type: initiation region
Name: UPP1_3
Description: uridine phosphorylase 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H11032 EPDNEW_H11033
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 7 48,089,369 - 48,089,429 EPDNEW
RGD ID: 6806384
Promoter ID: HG_KWN:57363
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid, NB4
Transcripts: ENST00000331803, NM_003364, NM_181597, OTTHUMT00000341750, OTTHUMT00000341755, OTTHUMT00000341757, OTTHUMT00000341758, OTTHUMT00000341759, OTTHUMT00000341760, UC003TOM.1, UC003TON.1, UC003TOO.1
Position: Human Assembly Chr Position (strand) Source Build 36 7 48,094,821 - 48,095,497 (+) MPROMDB
RGD ID: 6853040
Promoter ID: EP74341
Type: initiation region
Name: HS_UP
Description: Uridine phosphorylase.
SO ACC ID: SO:0000170
Source: EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Mammalian gene collection (MGC) full-length cDNA cloning
Position: Human Assembly Chr Position (strand) Source Build 36 7 48,095,372 - 48,095,432 EPD